These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16304144)

  • 1. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
    Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
    Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
    Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
    Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.
    Snoeck R; Holý A; Dewolf-Peeters C; Van Den Oord J; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3356-61. PubMed ID: 12384336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.
    Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
    Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
    J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections.
    De Clercq E; Neyts J
    Rev Med Virol; 2004; 14(5):289-300. PubMed ID: 15334537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs.
    Scagliarini A; McInnes CJ; Gallina L; Dal Pozzo F; Scagliarini L; Snoeck R; Prosperi S; Sales J; Gilray JA; Nettleton PF
    Antiviral Res; 2007 Mar; 73(3):169-74. PubMed ID: 17049627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses.
    Valiaeva N; Prichard MN; Buller RM; Beadle JR; Hartline CB; Keith KA; Schriewer J; Trahan J; Hostetler KY
    Antiviral Res; 2009 Dec; 84(3):254-9. PubMed ID: 19800369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Murono S; Raab-Traub N; Pagano JS
    Cancer Res; 2001 Nov; 61(21):7875-7. PubMed ID: 11691806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
    Neyts J; De Clercq E
    Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.
    Topalis D; Lebeau I; Krecmerová M; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2011 May; 55(5):1961-7. PubMed ID: 21343444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.